Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125259831 | 12525983 | 1 | I | 20160509 | 20160623 | 20160705 | 20160705 | EXP | US-DRREDDYS-USA/USA/16/0081001 | DR REDDYS | 77.87 | YR | F | Y | 107.50000 | KG | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125259831 | 12525983 | 1 | PS | MELOXICAM. | MELOXICAM | 1 | Oral | U | UNKNOWN | 77931 | 7.5 | MG | QD | ||||||
| 125259831 | 12525983 | 2 | SS | MELOXICAM. | MELOXICAM | 1 | Oral | U | UNKNOWN | 77931 | 7.5 | MG | QD | ||||||
| 125259831 | 12525983 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 325 | MG | QD | ||||||||
| 125259831 | 12525983 | 4 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 325 | MG | QD | ||||||||
| 125259831 | 12525983 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 6 | C | NITROSTAT | NITROGLYCERIN | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | 0 | |||||||||||
| 125259831 | 12525983 | 8 | C | Biotin | BIOTIN | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 9 | C | atorvastatin | ATORVASTATIN | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 0 | |||||||||||
| 125259831 | 12525983 | 12 | C | DULOXETINE. | DULOXETINE | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 13 | C | NYSTATIN. | NYSTATIN | 1 | Topical | 0 | |||||||||||
| 125259831 | 12525983 | 14 | C | triamcinolone | TRIAMCINOLONE | 1 | Topical | 0 | |||||||||||
| 125259831 | 12525983 | 15 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 16 | C | Vitamin B | VITAMIN B | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 17 | C | calcium | CALCIUM | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 18 | C | FLAXSEED | FLAX SEED | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 19 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 20 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 21 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 125259831 | 12525983 | 22 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125259831 | 12525983 | 1 | Sciatica |
| 125259831 | 12525983 | 3 | Cardiovascular disorder |
| 125259831 | 12525983 | 5 | Product used for unknown indication |
| 125259831 | 12525983 | 6 | Product used for unknown indication |
| 125259831 | 12525983 | 7 | Product used for unknown indication |
| 125259831 | 12525983 | 8 | Product used for unknown indication |
| 125259831 | 12525983 | 9 | Product used for unknown indication |
| 125259831 | 12525983 | 10 | Product used for unknown indication |
| 125259831 | 12525983 | 12 | Product used for unknown indication |
| 125259831 | 12525983 | 13 | Product used for unknown indication |
| 125259831 | 12525983 | 14 | Product used for unknown indication |
| 125259831 | 12525983 | 15 | Product used for unknown indication |
| 125259831 | 12525983 | 16 | Product used for unknown indication |
| 125259831 | 12525983 | 17 | Product used for unknown indication |
| 125259831 | 12525983 | 18 | Product used for unknown indication |
| 125259831 | 12525983 | 19 | Product used for unknown indication |
| 125259831 | 12525983 | 20 | Product used for unknown indication |
| 125259831 | 12525983 | 21 | Product used for unknown indication |
| 125259831 | 12525983 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125259831 | 12525983 | HO |
| 125259831 | 12525983 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125259831 | 12525983 | Abdominal pain upper | |
| 125259831 | 12525983 | Atelectasis | |
| 125259831 | 12525983 | Diverticulum | |
| 125259831 | 12525983 | Gastritis | |
| 125259831 | 12525983 | Hepatic steatosis | |
| 125259831 | 12525983 | Hiatus hernia | |
| 125259831 | 12525983 | Portal hypertension | |
| 125259831 | 12525983 | Pyrexia | |
| 125259831 | 12525983 | Renal cyst |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125259831 | 12525983 | 1 | 20141222 | 20160511 | 0 | |
| 125259831 | 12525983 | 2 | 20160516 | 0 | ||
| 125259831 | 12525983 | 3 | 2000 | 20160511 | 0 | |
| 125259831 | 12525983 | 4 | 20160516 | 0 | ||
| 125259831 | 12525983 | 5 | 201404 | 0 | ||
| 125259831 | 12525983 | 6 | 20141029 | 0 | ||
| 125259831 | 12525983 | 7 | 201405 | 0 | ||
| 125259831 | 12525983 | 8 | 20141121 | 0 | ||
| 125259831 | 12525983 | 9 | 20141210 | 0 | ||
| 125259831 | 12525983 | 10 | 2013 | 0 | ||
| 125259831 | 12525983 | 11 | 20160408 | 0 | ||
| 125259831 | 12525983 | 12 | 20150912 | 0 | ||
| 125259831 | 12525983 | 13 | 20160406 | 0 | ||
| 125259831 | 12525983 | 14 | 20160406 | 0 | ||
| 125259831 | 12525983 | 15 | 2013 | 0 | ||
| 125259831 | 12525983 | 16 | 2013 | 0 | ||
| 125259831 | 12525983 | 17 | 1970 | 0 | ||
| 125259831 | 12525983 | 18 | 2012 | 0 | ||
| 125259831 | 12525983 | 19 | 2013 | 0 | ||
| 125259831 | 12525983 | 20 | 2000 | 0 | ||
| 125259831 | 12525983 | 21 | 2000 | 0 | ||
| 125259831 | 12525983 | 22 | 20141125 | 0 |